9 results
- Go to itemIn virtual screening (VS), compounds similar to known ligands of a target under investigation often build the starting point for …1
- Go to itemNot all compounds are suitable starting points for drug development due to undesirable pharmacokinetic properties, which for inst…0
- Go to itemCompounds can contain unwanted substructures that may cause mutagenic, reactive, or other unfavorable pharmacokinetic effects or …0
- Go to itemClustering can be used to identify groups of similar compounds, in order to pick a set of diverse compounds from these clusters f…0
- Go to itemWhat is this? This is TeachOpenCADD KNIME (v1.0.3) reconfigured with KNIME 4.5. - Replaced deprecated nodes. - Adopted Workflow R…0
- Go to itemIn order to visualize shared scaffolds and thereby emphasize the extent and type of chemical similarities or differences of a com…0
- Go to itemInformation on compound structure, bioactivity and associated targets is organized in databases such as ChEMBL, PubChem, or DrugB…0